Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission to bring intranasal foralumab to patients in need. Their proven track ...

If you’ve ever wondered how Thon’s year-round fundraising efforts manage to raise that money, and where the money goes ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

The restoration of glycemic control through islet transplantation currently remains as one of the only approaches to achieve insulin independence for type-I ...